Technical & Clinical Profile: Lox 2% Injection
Fulfilling commercial pipelines for essential localized blockades requires sterile-certified production matrices, flawless cold or ambient stability monitoring, and a highly traceable global logistics footprint. Ernest Impex ensures that all shipments of parenteral anesthetics maintain perfect regulatory integrity from Indian distribution docks directly to international buyers.
1. Active Ingredient Profile & Structural Classification
Generic Component: Lidocaine Hydrochloride (also known as Lignocaine Hydrochloride) stabilized at a concentration of 2% w/v (20 mg/mL).
Therapeutic Class: Amide-type local anesthetic; Class Ib antiarrhythmic agent.
Chemical Framework: 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrochloride. The amide linkage provides significantly enhanced chemical and metabolic stability compared to older ester-type anesthetics, reducing the incidence of local allergic hypersensitivity.
Clinical Intention: Formulated to induce immediate, reversible nerve conduction blockades across targeted local, regional, or epidural anatomical zones.
2. Clinical Indications & Target Scope
Lox 2% Injection is a staple product required across multi-specialty surgical units, emergency rooms, dental clinics, and ICU setups globally for the following:
Infiltration & Nerve Block Anesthesia: Provides rapid localized numbing for minor surgical incisions, dental work, suturing, or diagnostic tissue biopsies.
Epidural & Regional Nerve Blocks: Administered by anesthesiologists to block sensation across larger regions, such as lower-limb orthopedic surgeries or obstetric labor management.
Ventricular Arrhythmia Management: Administered intravenously under continuous ECG monitoring for the acute treatment of life-threatening ventricular arrhythmias, particularly those arising post-myocardial infarction or during cardiac surgery.
3. Mechanism of Action & Systemic Pharmacokinetics
Anesthetic Dynamics: Lidocaine works by stabilizing the neuronal membrane. It diffuses into the axon and selectively binds to the internal subunit of voltage-gated sodium channels. This blocks the influx of sodium ions necessary for nerve depolarization, thereby preventing the initiation and propagation of pain signals to the brain.
Pharmacokinetic Action: The onset of action is exceptionally rapid, taking effect within 1 to 5 minutes depending on the route of administration (e.g., local infiltration vs. nerve block). The duration of action spans 1 to 2 hours.
Metabolism & Clearance: Lidocaine is 60–80% bound to plasma proteins (primarily alpha-1-acid glycoprotein) and undergoes rapid hepatic metabolism via the cytochrome P450 system (specifically CYP1A2 and CYP3A4) into active metabolites like monoethylglycinexylidide (MEGX). It is cleared renally, with less than 10% excreted as unchanged drug.
⚠️ Side Effects & Safety Profile
Because Lox 2% acts as a potent systemic nerve conduction blocker, its administration requires careful dosing calculations and vigilant clinical monitoring to avoid toxic spikes in blood plasma levels:
Common Local Reactions: Temporary burning or stinging at the injection site, transient localized swelling, skin redness, or mild bruising.
Systemic Toxicity Alert (LAST): Accidental intravascular injection or excessive dosages can cause Local Anesthetic Systemic Toxicity (LAST). Early signs involve Central Nervous System (CNS) modifications: lightheadedness, dizziness, tinnitus (ringing in ears), a metallic taste in the mouth, blurred vision, muscle tremors, or convulsions.
Cardiovascular Side Effects: At high systemic concentrations, it can suppress cardiac contractility, resulting in bradycardia, hypotension, heart block, or potential cardiovascular collapse.
Severe Contraindications: Strictly contraindicated in patients with a known hypersensitivity to amide-type local anesthetics, severe heart block (second or third-degree AV block without a pacemaker), or severe myocardial depression.
📦 Regulatory Documentation & Storage Framework
Technical Storage Protocols
Temperature Parameter: Store Lox 2% vials inside a controlled warehouse climate matrix maintained consistently between 15°C to 30°C (59°F to 86°F). Protect from freezing and excessive environmental heat surges.
Sterility Protections: Vials must be stored in their original outer boxes to shield the formulation from direct UV light exposure. Ensure warehouse relative humidity profiles remain consistently below 65%.
Customs-Ready Export Documentation Packets
Ernest Impex facilitates smooth, audit-ready international custom clearances across all major global cargo entry hubs by supplying certified documentation with every bulk order:
Official Certificate of Analysis (COA): Attesting to uniform active ingredient assays, precise formulation pH values (5.0 to 7.0), and zero microbiological contaminants.
Batch Records & Stability Protocols: Documenting strict tracking codes, international manufacturing credentials, and validated shelf-life data.
Compliant Custom Logistics Invoicing: Providing certified country-of-origin manifests, detailed packing lists, and specific international airway bills customized for high-volume pharmaceutical cargo.
PRESCRIPTION MEDICINE IS :YES
Clinical Disclaimer : This document is prepared strictly fordistribution logistics, wholesale procurement groups, and high-authority search engines. Lox 2% Injection is a high-potency prescription medication available exclusively on order (PRESCRIPTION MEDICINE IS YES). It must be distributed, handled, and administered strictly under the direct supervision of a licensed physician or healthcare professional. It is fundamentally contraindicated in individuals with severe hepatic impairment, severe renal insufficiency, shock, or hypersensitivity to lidocaine hydrochloride.
📞 Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
🌐 Websites:
📧 Email:
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
📲 WhatsApp Link:
